MDxHealth SA (MDXH)
0.6972
-0.02
(-2.28%)
USD |
NASDAQ |
Sep 09, 16:00
0.6972
0.00 (0.00%)
After-Hours: 16:50
MDxHealth Debt to Equity Ratio : -3.481 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.481 |
| March 31, 2026 | -5.234 |
| December 31, 2025 | -7.161 |
| September 30, 2025 | -10.64 |
| June 30, 2025 | -95.14 |
| March 31, 2025 | 14.07 |
| December 31, 2024 | 4.047 |
| Date | Value |
|---|---|
| September 30, 2024 | 3.256 |
| June 30, 2024 | -6.430 |
| March 31, 2024 | -42.24 |
| December 31, 2023 | 5.725 |
| September 30, 2023 | 2.283 |
| June 30, 2023 | 1.523 |
| March 31, 2023 | 1.051 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Myriad Genetics, Inc. | 0.6927 |
| BioRestorative Therapies, Inc. | 0.0114 |
| CareDx, Inc. | 0.0452 |
| Natera, Inc. | 0.1309 |
| Exagen, Inc. | 2.264 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 132.09M |
| Total Liabilities (Quarterly) | 162.49M |
| Shareholders Equity (Quarterly) | -30.40M |
| Current Ratio | 1.150 |
| Net Debt Paydown Yield | -20.74% |